Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MediPharm Labs Corp. Proxy Solicitation & Information Statement 2023

May 31, 2023

47498_rns_2023-05-30_706b0f4d-678c-47d2-9f81-47f300f4cde9.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [127 x 50] intentionally omitted <==

TSX TRUST COMPANY

VIA ELECTRONIC TRANSMISSION

May 30, 2023

TO ALL APPLICABLE EXCHANGES AND COMMISSIONS:

RE: MEDIPHARM LABS CORP.

We are pleased to confirm that copies of the following proxy-related materials were mailed on May 29, 2023 to the Registered Securityholders, to the Non-Objecting Beneficial Owners ("NOBO") and to the ESPP Holders:

  • 1 Proxy with Notice-and-Access Notice and Request for Financial Statements - Registered Securityholders

  • 2 Voting Instruction Form with Notice-and-Access Notice and Request for Financial Statements - NOBOs, ESPP Holders

  • 3 Notice of Meeting Combined with Information Circular - NOBOs Requesting Full Package

4 Virtual Meeting Guide Form

  • 5 Proxy Return Envelope

Yours truly, TSX Trust Company

''Lori Winchester''

Senior Relationship Manager [email protected]

VANCOUVER

650 West Georgia Street, Suite 2700 Vancouver, BC V6B 4N9 T 604 689-3334

CALGARY

300-5th Avenue SW, 10th floor Calgary, AB T2P 3C4

T 403 218-2800

TORONTO MONTRÉAL 301 - 100 Adelaide Street West 1800 - 1190, avenue des Toronto ON M5H 4H1 Canadiens-de-Montréal, C. P. 37 Montréal (Québec) H3B 0G7 Toll Free 1-866-600-5869 T 416 361-0930 T 514 395-5964